Michael Kassiou's molecule discovery leads to $273 million partnership

There is no doubt that psychiatric disorders like depression, schizophrenia, or dementia create ongoing challenges for both individuals affected as well as their loved ones.

Related Keywords

France ,Sydney ,New South Wales ,Australia ,Neos Kosmos ,Perifereia Peloponnisou ,Greece ,United States ,Australian ,Michael Kassiou ,Australian Nuclear Science ,Joliot Life Sciences ,Drug Discovery Initiative ,National Institute Of Drug Abuse ,University Of Sydney ,Boehringer Ingelheim ,Kinoxis Therapeutics ,Norganic Chemistry ,Johns Hopkins Medical Institutes ,Baltimore United ,Fogerty Fellow ,Drug Abuse ,Royal Prince Alfred Hospital ,Principal Hospital ,Medicinal Chemistry ,Academic Director ,Drug Discovery ,